Pipeline

Gyre offers the unique capability of advancing not only a core pipeline of programs for the treatment of fibrosis, inflammatory diseases and cancer, but also the ability to utilize its internal innovation capabilities to discover, evaluate and advance additional programs as part of its “China Innovation” engine.
 

Robust Portfolio: Fibrosis, Inflammatory Diseases, Cancer and China Innovation